Effect of irinotecan hydrochloride combined with cisplatin on Bcl-2 and MACC1 protein expressions in cervical epithelial tissue of cervical cancer patients
- VernacularTitle:盐酸伊立替康联合顺铂方案对宫颈癌患者宫颈上皮组织Bcl-2及MACC1蛋白表达的影响
- Author:
Xuan LI
;
Li ZHAGN
;
Yingqun LIU
- Publication Type:Journal Article
- Keywords:
irinotecan hydrochloride;
cisplatin;
cervical cancer;
Bcl-2;
MACC1
- From:
Chinese Journal of Biochemical Pharmaceutics
2015;(11):86-88,91
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of irinotecan hydrochloride combined with cisplatin on B-cell lymphoma-2 (Bcl-2) and metastasis-associated in colon cancer-1 (MACC1) protein expressions in cervical epithelial tissue of cervical cancer patients.Methods 100 patients with cervical cancer from January 2010 to January 2013 in Department of Obstetrics and Gynecology of Shangrao City People's Hospital were selected as objects.All patients were treated with irinotecan hydrochloride and cisplatin for combination chemotherapy.The clinical effect and the protein expressions of Bcl-2 and MACC1 of cervical epithelial tissue were compared pre-and post-chemotherapy.Results The total efficiency was 75.0%(75/100) after cervical cancer patients were given irinotecan hydrochloride combined with cisplatin chemotherapy program.The expressions and high expression rates of Bcl-2 and MACC1 post-chemotherapy were significantly lower than that pre-chemotherapy(P<0.05) .In clinically effective group, the high expression rates of Bcl-2 and MACC1 post-chemotherapy significantly reduced than pre-treatment (P<0.05), and in clinical invalid group, the difference of the high expression rates of Bcl-2 and MACC1 had no statistically significant.Conclusion After combination chemotherapy with irinotecan hydrochloride and cisplatin on cervical cancer, the expression of Bcl-2 and MACC1 in cervical epithelial tissue significantly reduce, and the clinical efficacy is aignificant.
